AnalystsDae Gon HaDae Gon Ha's Stock Forecasts
AnalystsDae Gon Ha
Sectors:
Industries:
Analyst Ranking
Bottom 15%
#4198 out of 4922 analysts
Average Return
-1.33%
Win Rate
33%15 out of 45
Risk vs Reward
Poor
Good
Dae Gon Ha's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Rhythm Pharmaceuticals IncRYTM | +367.51% | $3.94 | $18.42 | 2022-06-17 - 2023-06-16 | Strong Buy |
Equillium IncEQ | +288.97% | $0.73 | $2.82 | 2023-03-24 - 2024-03-22 | Strong Buy |
Krystal Biotech IncKRYS | +90.61% | $89.00 | $169.64 | 2023-04-18 - 2024-04-17 | Strong Buy |
Fulcrum Therapeutics IncFULC | +75.69% | $5.43 | $9.54 | 2023-08-22 - 2024-08-21 | Strong Buy |
Chemocentryx IncCCXI | +75.05% | $14.47 | $25.33 | 2021-07-07 - 2022-07-06 | Strong Buy |
Dae Gon Ha Analyst Color
Get additional color on Dae Gon Ha's coverage of popular stocks
Dae Gon Ha's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Abeona Therapeutics IncABEO | 2 | Strong Buy | $20.00 | +247.83% | Maintains | a month ago |
Editas Medicine IncEDIT | 4 | Hold | $3.00 | +31.58% | Downgrades | 7 months ago |
Soleno Therapeutics IncSLNO | 2 | Strong Buy | $74.00 | -11.11% | Maintains | 9 months ago |
Fulcrum Therapeutics IncFULC | 4 | Hold | $3.00 | -57.75% | Downgrades | 10 months ago |
Inozyme Pharma IncINZY | 1 | Strong Buy | $16.00 | +301.00% | Initiates Coverage On | 10 months ago |
Intellia Therapeutics IncNTLA | 2 | Strong Buy | $64.00 | +569.46% | Maintains | 10 months ago |
Krystal Biotech IncKRYS | 4 | Strong Buy | $220.00 | +58.41% | Maintains | 10 months ago |
Mirum Pharmaceuticals IncMIRM | 3 | Strong Buy | $66.00 | N/A | Maintains | a year ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $127.00 | N/A | Maintains | a year ago |
Verve Therapeutics IncVERV | 3 | Strong Buy | $40.00 | N/A | Maintains | a year ago |
Orchard Therapeutics PLCORTX | 1 | Hold | $16.00 | N/A | Downgrades | 2 years ago |
Rocket Pharmaceuticals IncRCKT | 4 | Strong Buy | $48.00 | N/A | Reiterates | 2 years ago |
Freeline Therapeutics Holdings PLCFRLN | 4 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Prime Medicine IncPRME | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Equillium IncEQ | 1 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Applied Genetic Technologies CorpAGTC | 3 | Hold | $0.34 | N/A | Downgrades | 3 years ago |
Chemocentryx IncCCXI | 5 | Hold | $52.00 | N/A | Downgrades | 3 years ago |
Rhythm Pharmaceuticals IncRYTM | 1 | Strong Buy | $25.00 | N/A | Maintains | 3 years ago |
Amicus Therapeutics IncFOLD | 3 | Strong Buy | $16.00 | N/A | Upgrades | 4 years ago |
Surrozen IncSRZN | 1 | Strong Buy | $285.00 | N/A | Initiates Coverage On | 4 years ago |
Proqr Therapeutics NvPRQR | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 4 years ago |
Q32 Bio IncQTTB | 1 | Hold | $252.00 | N/A | Initiates Coverage On | 4 years ago |
Tectonic Therapeutic IncTECX | 1 | Hold | $168.00 | N/A | Initiates Coverage On | 4 years ago |
Apellis Pharmaceuticals IncAPLS | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Biocryst Pharmaceuticals IncBCRX | 1 | Hold | N/A | N/A | Initiates Coverage On | 5 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Strong Buy | $660.00 | N/A | Initiates Coverage On | 5 years ago |
Inflarx NvIFRX | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 5 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $237.00 | N/A | Initiates Coverage On | 5 years ago |
Dbv Technologies SaDBVT | 2 | Buy | $490.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.